Authorization shall be valid for five years and shall be renewable for five-year periods, on application by the holder at least three months before the expiry date and after consideration by the competent authority of a dossier containing in particular details of the data on pharmacovigilance and other information relevant to the monitoring of the medicinal product.
Home› Food & Health Safety› Community Code on Medicinal Products
Chapter 3 · Procedures relevant to the marketing authorization › Article 24
Article 24
←→ also move between articles